TY  - GEN
AU  - Hanefeld,M
TI  - Clinical rationale for rosuvastatin, a potent new HMG-CoA reductase inhibitor
SN  - 1368-5031
PY  - 2001///0927
KW  - Coronary Disease
KW  - prevention & control
KW  - Fluorobenzenes
KW  - pharmacology
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hyperlipidemias
KW  - drug therapy
KW  - Pyrimidines
KW  - Rosuvastatin Calcium
KW  - Sulfonamides
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Review
ER  -